Little Things Matter: The Impact of Toxins on the Developing Brain

Bruce Lanphear

Aducanumab FDA Approval for Alzheimer's Disease: The Importance of G…

Anton Porsteinsson

Myths and Misconceptions About Parkinson Disease: What Is a Role of …

Mayo Clinic Proceedings

E. Ahlskog

Lewy Body Dementia: The Most Common Disease You Never Heard Of

University of Miami

J. Galvin

Conference Highlights: Diagnosing Vascular Cognitive Impairment and …

2024 Conference Highlights

P. Sachdev

Surgical Options for Patients With Parkinson’s Disease and Other Mov…

Cedars Sinai

A. Mamelak

Approach to Cognitive Impairment in Adults

ZINCARE

M. Mataa

Cognitive Disorders

ZINCARE

M. Mataa

PD GENEration

Parkinson's Foundation

R. N. Alcalay

Parkinson’s Disease: The Exercise Prescription and Rationale

University of Utah Neurology

D. M. Corcos

Updates in Dementia

2023 Conference Coverage

P. Tipton

Unmet Needs of Women Living WithParkinson’s Disease: Research & Ma…

Indu Subramanian

Unpacking Parkinsonism: Understanding Movement Changes in LBD

Lewy Body Dementia Association

J. Fleisher

Lewy Body Dementia: The Most Common Disease You Never Heard Of - 2024

AdventHealth

J. Galvin

Not Your Grandmother's Dopamine: Pairing Clinical Studies With Dopam…

PMD Alliance

F. L. Pagán

Preventing Cognitive Decline with Lithium

Psychiatry Redefined

J. Greenblatt

A New Era for Brain Health in Primary Care: New Drugs and Diagnostics

University of Kansas Medical Center

J. M. Burns

Frontotemporal Dementias and Selective Neuronal Vulnerability

BRAIN PONDERINGS podcast with Mark Mattson

W. Seeley, M. Mattson

Initial Treatment of Parkinson’s Disease

University of Miami

D. Shpiner

Approach to Movement Disorders

ZINCARE

A. Chishimba